跳至主要内容
临床试验/IRCT2015102316844N2
IRCT2015102316844N2已完成2 期

Comparison the effect of Topiramate and Amitriptyline Prophylactic therapy on cyclic vomiting syndrome in Pediatrics

Vice Chancellor for Research of Isfahan University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
3 years 至 15 years(—)
性别
All

入选标准

  • Children 3-15
  • years old with diagnosis of cyclic vomiting syndrome (based on Rome III criteria: 1 Stereotypical episodes of vomiting regarding onset (acute) and duration (less than 1 week); 2) Three or more discrete episodes in the prior year; and 3) Absence of nausea and vomiting between episodes and absence of metabolic, gastrointestinal, central nervous system structural or biochemical disorders); Normal Neurological and Developmental examination Exclusion criteria: Known metabolic disease; Obstructive disease of gastrointestinal or urinary system; Patients who don't give consent to participate in the study or want to leave the study anytime.

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for Research of Isfahan University of Medical Sciences

相似试验